1. RESEARCH OBJECTIVES AND ASSUMPTIONS

• Research Objectives
• Assumptions
• Abbreviations

2. MARKET PURVIEW

• Report Description
• Market Definition and Scope
• Executive Summary
• Global Chronic Pain Market, By Drug Class
• Global Chronic Pain Market, By Indication
• Global Chronic Pain Market, By Application
• Global Chronic Pain Market, By Distribution Channel
• Global Chronic Pain Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER’s Analysis
• Merger and Acquisition Scenario

4. Global Chronic Pain Market, By Drug Class, 2021 - 2033, (USD Bn)

• Introduction
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2022 - 2033
• Segment Trends
• Opioids
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Non-steroidal anti-inflammatory drugs (NSAIDS)
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Anticonvulsants
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Antidepressants
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Others
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Global Chronic Pain Market, By Indication, 2021 - 2033, (USD Bn)

• Introduction
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2022 - 2033
• Segment Trends
• Neuropathic pain
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Arthritis pain
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Chronic back pain
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Cancer pain
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Migraine
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Fibromyalgia
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Others
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Chronic Pain Market, By Application, 2021 - 2033, (USD Bn)

• Introduction
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2022 - 2033
• Segment Trends
• Musculoskeletal
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Neuropathy
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Oncology
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Others
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Chronic Pain Market, By Distribution Channel, 2021 - 2033, (USD Bn)

• Introduction
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2022 - 2033
• Segment Trends
• Hospital Pharmacies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Retail Pharmacies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Online Pharmacies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global Chronic Pain Market, By Region, 2021 - 2033, (USD Bn)

• Introduction
• Market Share (%) Analysis, 2026,2028 & 2033, (USD Bn)
• Market Y-o-Y Growth Analysis (%), 2022 - 2033, (USD Bn)
• Regional Trends
• North America
• Introduction
• Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Indication, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
• U.S.
• Canada
• Latin America
• Introduction
• Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Indication, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Europe
• Introduction
• Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Indication, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
• Introduction
• Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Indication, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• Introduction
• Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Indication, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
• GCC Countries
• Israel
• Rest of Middle East
• Africa
• Introduction
• Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Indication, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Country/Region, 2021 - 2033, (USD Bn)
• South Africa
• North Africa
• Central Africa

9. Competitive Landscape

• Pfizer Inc.
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• Johnson & Johnson
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• GlaxoSmithKline PLC
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• Bayer AG
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• Novartis AG
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• Endo Pharmaceuticals
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• Bristol-Myers Squibb
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• Eli Lilly and Company
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• Teva Pharmaceutical Industries Ltd.
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• Reckitt Benckiser Group plc
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• Medtronic plc
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• AstraZeneca PLC
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• Becton, Dickinson and Company
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• AbbVie Inc.
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• Horizon Therapeutics
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• Mallinckrodt Pharmaceuticals
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• Zynerba Pharmaceuticals
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• Neurocrine Biosciences
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• Sorrento Therapeutics
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• Cypress Pharmaceutical
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us